Reduction in visceral adiposity is associated with an improved metabolic profile in HIV-infected patients receiving tesamorelin. (Q34637395)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Reduction in visceral adiposity is associated with an improved metabolic profile in HIV-infected patients receiving tesamorelin.
scientific article

    Statements

    Reduction in visceral adiposity is associated with an improved metabolic profile in HIV-infected patients receiving tesamorelin (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit